Skip to main content
. 2023 Jul 25;15(7):3908–3918. doi: 10.21037/jtd-23-923

Table 3. Comparison of risk factor in PPCs.

Characteristics Primary cohort PSM cohort
Non-PPC (n=314) PPC (n=142) P value Non-PPC (n=135) PPC (n=135) P value
Pathologic stage 0.02 0.07
   I 184 (58.6) 64 (45.1) 81 (60.0) 63 (46.7)
   II 73 (23.2) 40 (28.2) 31 (23.0) 37 (27.4)
   III 57 (18.2) 38 (26.8) 23 (17.0) 35 (25.9)
Side of resection 0.79 0.9
   Right lobe 182 (58.0) 83 (58.5) 79 (58.5) 80 (59.3)
   Left lobe 132 (42.0) 59 (41.5) 56 (41.5) 55 (40.7)
Surgical approach 0.03 0.045
   Open thoracotomy 80 (25.5) 54 (38.0) 35 (25.9) 49 (36.3)
   VATS 234 (74.5) 88 (62.0) 100 (74.1) 86 (63.7)
Resection type 0.04 0.22
   More than lobectomy 22 (7.0) 20 (14.1) 11 (8.1) 20 (14.8)
   Lobectomy 236 (75.2) 95 (66.9) 96 (71.1) 88 (65.2)
   Sublobar resection 56 (17.8) 27 (19.0) 28 (20.7) 27 (20.0)
Histology 0.46 0.99
   Adenocarcinoma 227 (72.3) 96 (67.6) 93 (68.9) 92 (68.1)
   Squamous-cell carcinoma 81 (25.8) 44 (30.9) 40 (29.6) 41 (30.4)
   Others 6 (1.9) 2 (1.4) 2 (1.5) 2 (1.5)
Surgical duration (min) 170.00±71.40 186.90±71.52 0.02 171.89±74.49 187.74±71.91 0.07
Perioperative bleeding (mL) 140.94±145.12 196.83±267.52 0.02 158.70±167.27 190.37±268.87 0.24
Perioperative fluid infusion (mL) 1,629.30±442.29 1,716.90±502.22 0.06 1,634.44±462.97 1,701.11±484.17 0.24
Perioperative blood transfusion 8 (2.5) 9 (6.3) 0.04 4 (3.0) 8 (5.9) 0.23
ASA classification 0.01 0.036
   ≤ II 309 (98.4) 131 (92.3) 133 (98.5) 125 (92.6)
   > II 5 (1.6) 11 (7.7) 2 (1.5) 10 (7.4)

Data are presented as mean ± standard deviation or n (%). PPC, postoperative pulmonary complications; PSM, propensity score matching; VATS, video-assisted thoracoscopic surgery; ASA, American Society of Anesthesiologists.